OR WAIT 15 SECS
Spectra254, a developer of high-power, easy-to-use, affordable UV-C light decontamination systems, announced that the results from an independent laboratory study show Spectra254’s Spectra 500 ultraviolet light system, the company’s first system designed to decontaminate smaller spaces such as medical transport vehicles, is 99.9 percent effective in killing an Ebola surrogate virus, becoming the second system from Spectra254 to be proven to kill the surrogate virus.
Performed by Antimicrobial Test Laboratories, the study found the Spectra 500 ultraviolet light system is 99.9 percent effective at killing the Ebola surrogate on surfaces in as little as 10 minutes. The laboratory measured efficacy at a distance of six feet, both vertically and horizontally, as well as efficacy at varying horizontal heights. The study tested the microorganism Feline calicivirus (FCV), the closest to the real virus that can legally be tested, and which also meets the CDC Ebola Disinfection Guidelines for Selection of Appropriate Test Virus.
“The Spectra 500 is compact and portable, and it was designed specifically to decontaminate emergency vehicles,” says Sanford Green, president of Spectra254. “Paramedics and EMTs need proven sanitation tools that can quickly eliminate deadly pathogens on surfaces, particularly when providing emergency care to patients who require immediate, life-saving medical assistance.”
The Spectra 500 is compact, lightweight and mobile, and includes a 360-degree motion detection safety feature. The Spectra 500 UVC light decontamination system uses high-intensity ultraviolet light to eliminate pathogens on surfaces. The system was designed specifically to eliminate HAIs on surfaces, such as MRSA and C. difficile spores.
This is the second Spectra254 UVC light decontamination system to undergo an Ebola elimination efficacy test. Spectra254’s 1000 Series ultraviolet light system was tested in an independent laboratory study in November 2014. Results of the study showed the 1000 Series system is 99.9 percent effective in eliminating the Ebola surrogate virus as well.